Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nereid Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Nereid Therapeutics

Nereid Therapeutics

Nereid Therapeutics: Innovating drug discovery with proprietary technologies for new disease treatments.

HQ
Boston, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Nereid Therapeutics, founded by Clifford Brangwynne, Ph.D., focuses on discovering new disease treatments through proprietary technologies that generate, visualize, and measure liquid-liquid phase separation (LLPS) and biomolecular condensates. The company's mission is to translate the therapeutic promise of these scientific principles into effective treatments, bridging the gap from physics to physicians. Their innovative approach targets a broad market in the pharmaceutical and biotechnology sectors.

Notable figures affiliated with Nereid Therapeutics include Clifford Brangwynne, a pioneer in the biomolecular condensate field. The company has garnered attention for its cutting-edge research and potential to revolutionize drug discovery. While specific investors are not mentioned, the impact of Nereid Therapeutics is significant, as it leverages advanced scientific discoveries to address unmet medical needs, positioning itself as a leader in next-generation therapeutics.

Nereid Therapeutics - Similar Companies

Faze Medicines logo

Faze Medicines

fazemed.com

Nerio Therapeutics logo

Nerio Therapeutics

Transition Bio logo

Transition Bio

transitionbio.com

Dewpoint Therapeutics logo

Dewpoint Therapeutics

dewpointx.com

Nextrna Therapeutics logo

Nextrna Therapeutics

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

NeuroX1 logo

NeuroX1

neurox1.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

20n Bio logo

20n Bio

20n.bio

Nerx Biosciences logo

Nerx Biosciences

Nido Biosciences logo

Nido Biosciences

nidobio.com

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

NED Biosystems logo

NED Biosystems

nedbiosystems.com

NephroDI Therapeutics logo

NephroDI Therapeutics

nephrodi.com

Nereid Therapeutics - Quick Facts

Who are Nereid Therapeutics' competitors?

Companies similar to Nereid Therapeutics include Faze Medicines, Nerio Therapeutics, Transition Bio and Dewpoint Therapeutics.

When was Nereid Therapeutics founded?

Nereid Therapeutics was founded in 2020.

Where is Nereid Therapeutics' headquarters located?

Nereid Therapeutics' headquarters is located in Boston, MA, US.

When was Nereid Therapeutics' last funding round?

Nereid Therapeutics' most recent funding round was for $50M (USD) in November 2020.

How much has Nereid Therapeutics raised to-date?

As of Nov 16, 2020, Nereid Therapeutics has raised a total of $50M (USD).

How many employees does Nereid Therapeutics have?

Nereid Therapeutics has 12 employees as of Feb 5, 2024.

Nereid Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified